WideTrial Supports NIH-Funded Expanded Access Program for Investigational ALS Drug ...Middle East

Program to provide investigational drug to ALS patients who would otherwise be ineligible for clinical trials SANTA CLARA, Calif., Nov. 20, 2024 /PRNewswire/ -- WideTrial, an innovator of expanded access program (EAP) solutions, announced its participation in an NIH-funded collaboration...

Hence then, the article about widetrial supports nih funded expanded access program for investigational als drug was published today ( Wednesday 20/11/2024 - 02:08 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( WideTrial Supports NIH-Funded Expanded Access Program for Investigational ALS Drug )

Also on site :

• EU ‘not competitive’ – Belgian central bank chief
• Pakistan Opens Iran Land Corridors as Region Scrambles for Routes Beyond Hormuz
• LG Display presents future of displays with next-generation OLED technologies at SID Display Week 2026